Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema February 4, 2025 by Projesh Kar Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema Share this:FacebookXLike this:Like Loading... Related Share this content: Projesh Kar I am a passionate blogger with extensive experience in web design. As a seasoned YouTube SEO expert, I have helped numerous creators optimize their content for maximum visibility. Contact